nodes	percent_of_prediction	percent_of_DWPC	metapath
Levomilnacipran—SLC6A2—sympathetic nervous system—metabolic syndrome X	0.0441	0.231	CbGeAlD
Levomilnacipran—CYP2J2—artery—metabolic syndrome X	0.0354	0.185	CbGeAlD
Levomilnacipran—SLC6A2—autonomic nervous system—metabolic syndrome X	0.0297	0.155	CbGeAlD
Levomilnacipran—CYP2J2—blood vessel—metabolic syndrome X	0.0276	0.144	CbGeAlD
Levomilnacipran—Contusion—Metformin—metabolic syndrome X	0.0126	0.0465	CcSEcCtD
Levomilnacipran—Chest discomfort—Metformin—metabolic syndrome X	0.0124	0.0459	CcSEcCtD
Levomilnacipran—CYP2J2—cardiovascular system—metabolic syndrome X	0.0123	0.0644	CbGeAlD
Levomilnacipran—Migraine—Metformin—metabolic syndrome X	0.00786	0.029	CcSEcCtD
Levomilnacipran—CYP2J2—liver—metabolic syndrome X	0.00762	0.0398	CbGeAlD
Levomilnacipran—Liver function test abnormal—Metformin—metabolic syndrome X	0.00737	0.0272	CcSEcCtD
Levomilnacipran—Breast disorder—Metformin—metabolic syndrome X	0.00721	0.0266	CcSEcCtD
Levomilnacipran—Abdominal distension—Metformin—metabolic syndrome X	0.00694	0.0256	CcSEcCtD
Levomilnacipran—Angina pectoris—Metformin—metabolic syndrome X	0.00672	0.0248	CcSEcCtD
Levomilnacipran—Neutropenia—Metformin—metabolic syndrome X	0.00645	0.0238	CcSEcCtD
Levomilnacipran—Upper respiratory tract infection—Metformin—metabolic syndrome X	0.00641	0.0237	CcSEcCtD
Levomilnacipran—Hepatobiliary disease—Metformin—metabolic syndrome X	0.00582	0.0215	CcSEcCtD
Levomilnacipran—Hepatitis—Metformin—metabolic syndrome X	0.00552	0.0204	CcSEcCtD
Levomilnacipran—Hypoaesthesia—Metformin—metabolic syndrome X	0.00549	0.0203	CcSEcCtD
Levomilnacipran—Oedema peripheral—Metformin—metabolic syndrome X	0.00544	0.0201	CcSEcCtD
Levomilnacipran—Connective tissue disorder—Metformin—metabolic syndrome X	0.00543	0.02	CcSEcCtD
Levomilnacipran—ABCB1—blood vessel—metabolic syndrome X	0.00516	0.027	CbGeAlD
Levomilnacipran—Eye disorder—Metformin—metabolic syndrome X	0.00516	0.0191	CcSEcCtD
Levomilnacipran—Cardiac disorder—Metformin—metabolic syndrome X	0.00512	0.0189	CcSEcCtD
Levomilnacipran—Flushing—Metformin—metabolic syndrome X	0.00512	0.0189	CcSEcCtD
Levomilnacipran—Angiopathy—Metformin—metabolic syndrome X	0.00501	0.0185	CcSEcCtD
Levomilnacipran—Mediastinal disorder—Metformin—metabolic syndrome X	0.00498	0.0184	CcSEcCtD
Levomilnacipran—Chills—Metformin—metabolic syndrome X	0.00495	0.0183	CcSEcCtD
Levomilnacipran—Malnutrition—Metformin—metabolic syndrome X	0.00481	0.0177	CcSEcCtD
Levomilnacipran—Flatulence—Metformin—metabolic syndrome X	0.00474	0.0175	CcSEcCtD
Levomilnacipran—Dysgeusia—Metformin—metabolic syndrome X	0.00471	0.0174	CcSEcCtD
Levomilnacipran—CYP2C8—kidney—metabolic syndrome X	0.0047	0.0246	CbGeAlD
Levomilnacipran—Vision blurred—Metformin—metabolic syndrome X	0.00453	0.0167	CcSEcCtD
Levomilnacipran—Tremor—Metformin—metabolic syndrome X	0.0045	0.0166	CcSEcCtD
Levomilnacipran—Syncope—Metformin—metabolic syndrome X	0.00431	0.0159	CcSEcCtD
Levomilnacipran—Palpitations—Metformin—metabolic syndrome X	0.00425	0.0157	CcSEcCtD
Levomilnacipran—Loss of consciousness—Metformin—metabolic syndrome X	0.00422	0.0156	CcSEcCtD
Levomilnacipran—Hypertension—Metformin—metabolic syndrome X	0.00415	0.0153	CcSEcCtD
Levomilnacipran—Chest pain—Metformin—metabolic syndrome X	0.00409	0.0151	CcSEcCtD
Levomilnacipran—Unspecified disorder of skin and subcutaneous tissue—Metformin—metabolic syndrome X	0.00406	0.015	CcSEcCtD
Levomilnacipran—Infection—Metformin—metabolic syndrome X	0.0039	0.0144	CcSEcCtD
Levomilnacipran—Shock—Metformin—metabolic syndrome X	0.00386	0.0142	CcSEcCtD
Levomilnacipran—Nervous system disorder—Metformin—metabolic syndrome X	0.00385	0.0142	CcSEcCtD
Levomilnacipran—Thrombocytopenia—Metformin—metabolic syndrome X	0.00384	0.0142	CcSEcCtD
Levomilnacipran—Skin disorder—Metformin—metabolic syndrome X	0.00381	0.0141	CcSEcCtD
Levomilnacipran—Hyperhidrosis—Metformin—metabolic syndrome X	0.00379	0.014	CcSEcCtD
Levomilnacipran—Anorexia—Metformin—metabolic syndrome X	0.00374	0.0138	CcSEcCtD
Levomilnacipran—Hypotension—Metformin—metabolic syndrome X	0.00367	0.0135	CcSEcCtD
Levomilnacipran—Paraesthesia—Metformin—metabolic syndrome X	0.00352	0.013	CcSEcCtD
Levomilnacipran—Dyspnoea—Metformin—metabolic syndrome X	0.0035	0.0129	CcSEcCtD
Levomilnacipran—Somnolence—Metformin—metabolic syndrome X	0.00349	0.0129	CcSEcCtD
Levomilnacipran—Dyspepsia—Metformin—metabolic syndrome X	0.00345	0.0127	CcSEcCtD
Levomilnacipran—Decreased appetite—Metformin—metabolic syndrome X	0.00341	0.0126	CcSEcCtD
Levomilnacipran—CYP2C19—liver—metabolic syndrome X	0.0034	0.0178	CbGeAlD
Levomilnacipran—Gastrointestinal disorder—Metformin—metabolic syndrome X	0.00339	0.0125	CcSEcCtD
Levomilnacipran—Fatigue—Metformin—metabolic syndrome X	0.00338	0.0125	CcSEcCtD
Levomilnacipran—Constipation—Metformin—metabolic syndrome X	0.00335	0.0124	CcSEcCtD
Levomilnacipran—Gastrointestinal pain—Metformin—metabolic syndrome X	0.00321	0.0118	CcSEcCtD
Levomilnacipran—CYP3A4—kidney—metabolic syndrome X	0.00318	0.0166	CbGeAlD
Levomilnacipran—CYP2D6—kidney—metabolic syndrome X	0.00313	0.0164	CbGeAlD
Levomilnacipran—Urticaria—Metformin—metabolic syndrome X	0.00312	0.0115	CcSEcCtD
Levomilnacipran—Abdominal pain—Metformin—metabolic syndrome X	0.0031	0.0114	CcSEcCtD
Levomilnacipran—CYP2C8—liver—metabolic syndrome X	0.00297	0.0155	CbGeAlD
Levomilnacipran—Asthenia—Metformin—metabolic syndrome X	0.00281	0.0104	CcSEcCtD
Levomilnacipran—Pruritus—Metformin—metabolic syndrome X	0.00278	0.0102	CcSEcCtD
Levomilnacipran—Diarrhoea—Metformin—metabolic syndrome X	0.00268	0.00991	CcSEcCtD
Levomilnacipran—Dizziness—Metformin—metabolic syndrome X	0.00259	0.00958	CcSEcCtD
Levomilnacipran—Vomiting—Metformin—metabolic syndrome X	0.00249	0.00921	CcSEcCtD
Levomilnacipran—Rash—Metformin—metabolic syndrome X	0.00247	0.00913	CcSEcCtD
Levomilnacipran—Dermatitis—Metformin—metabolic syndrome X	0.00247	0.00912	CcSEcCtD
Levomilnacipran—Headache—Metformin—metabolic syndrome X	0.00246	0.00907	CcSEcCtD
Levomilnacipran—Nausea—Metformin—metabolic syndrome X	0.00233	0.0086	CcSEcCtD
Levomilnacipran—ABCB1—cardiovascular system—metabolic syndrome X	0.0023	0.012	CbGeAlD
Levomilnacipran—ABCB1—kidney—metabolic syndrome X	0.00225	0.0118	CbGeAlD
Levomilnacipran—ABCB1—adipose tissue—metabolic syndrome X	0.00203	0.0106	CbGeAlD
Levomilnacipran—CYP3A4—liver—metabolic syndrome X	0.00201	0.0105	CbGeAlD
Levomilnacipran—CYP2D6—liver—metabolic syndrome X	0.00198	0.0103	CbGeAlD
Levomilnacipran—ABCB1—liver—metabolic syndrome X	0.00142	0.00744	CbGeAlD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—metabolic syndrome X	0.000248	0.000461	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—HMGCR—metabolic syndrome X	0.000245	0.000456	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—FMO3—metabolic syndrome X	0.000245	0.000455	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—MLXIPL—metabolic syndrome X	0.000244	0.000454	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—EPHX2—metabolic syndrome X	0.000244	0.000454	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—CETP—metabolic syndrome X	0.000242	0.00045	CbGpPWpGaD
Levomilnacipran—ABCB1—HIF-1-alpha transcription factor network—AKT1—metabolic syndrome X	0.000242	0.000449	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—FMO3—metabolic syndrome X	0.000239	0.000444	CbGpPWpGaD
Levomilnacipran—ABCB1—Transmembrane transport of small molecules—GCK—metabolic syndrome X	0.000233	0.000433	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—SCARB1—metabolic syndrome X	0.000232	0.000431	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—G6PC2—metabolic syndrome X	0.00023	0.000427	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—FMO3—metabolic syndrome X	0.000225	0.000419	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—SREBF1—metabolic syndrome X	0.000225	0.000418	CbGpPWpGaD
Levomilnacipran—ABCB1—Transmembrane transport of small molecules—CETP—metabolic syndrome X	0.000224	0.000417	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—PPARG—metabolic syndrome X	0.000223	0.000415	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—INS—metabolic syndrome X	0.000219	0.000407	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—HMGCR—metabolic syndrome X	0.000219	0.000407	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—ABCA1—metabolic syndrome X	0.000218	0.000406	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—MLXIPL—metabolic syndrome X	0.000218	0.000406	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—EPHX2—metabolic syndrome X	0.000218	0.000406	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—EPHX2—metabolic syndrome X	0.000213	0.000396	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—MLXIPL—metabolic syndrome X	0.000213	0.000396	CbGpPWpGaD
Levomilnacipran—SLC6A2—Transmembrane transport of small molecules—ALB—metabolic syndrome X	0.000212	0.000394	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—GGT1—metabolic syndrome X	0.000212	0.000393	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—metabolic syndrome X	0.000205	0.000382	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—G6PC2—metabolic syndrome X	0.000205	0.000381	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—ALB—metabolic syndrome X	0.000201	0.000373	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—MLXIPL—metabolic syndrome X	0.000201	0.000373	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—EPHX2—metabolic syndrome X	0.000201	0.000373	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—G6PC2—metabolic syndrome X	0.0002	0.000372	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—FABP4—metabolic syndrome X	0.000195	0.000363	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—ABCA1—metabolic syndrome X	0.000195	0.000363	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—NOS3—metabolic syndrome X	0.000192	0.000357	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—GGT1—metabolic syndrome X	0.000189	0.000351	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—G6PC2—metabolic syndrome X	0.000189	0.000351	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—HSD11B1—metabolic syndrome X	0.000185	0.000344	CbGpPWpGaD
Levomilnacipran—ABCB1—Transmembrane transport of small molecules—SLC2A4—metabolic syndrome X	0.000181	0.000336	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—APOB—metabolic syndrome X	0.00018	0.000334	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—PTGS2—metabolic syndrome X	0.000176	0.000327	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G4A—metabolic syndrome X	0.000175	0.000325	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—FABP4—metabolic syndrome X	0.000174	0.000324	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—LPL—metabolic syndrome X	0.000171	0.000319	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—FABP4—metabolic syndrome X	0.00017	0.000316	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—HSD11B1—metabolic syndrome X	0.000165	0.000307	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—G6PD—metabolic syndrome X	0.000165	0.000307	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—CD36—metabolic syndrome X	0.000163	0.000303	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—HSD11B1—metabolic syndrome X	0.000161	0.0003	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—HDAC3—metabolic syndrome X	0.000161	0.0003	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—FABP4—metabolic syndrome X	0.00016	0.000298	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—APOB—metabolic syndrome X	0.00016	0.000298	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—LPA—metabolic syndrome X	0.000157	0.000293	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—GCKR—metabolic syndrome X	0.000157	0.000293	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4A—metabolic syndrome X	0.000156	0.00029	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—LPL—metabolic syndrome X	0.000153	0.000285	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—PLA2G6—metabolic syndrome X	0.000153	0.000284	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—HSD11B1—metabolic syndrome X	0.000152	0.000283	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—metabolic syndrome X	0.000151	0.000282	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—APOA5—metabolic syndrome X	0.000151	0.000281	CbGpPWpGaD
Levomilnacipran—ABCB1—Transmembrane transport of small molecules—APOB—metabolic syndrome X	0.000149	0.000277	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—metabolic syndrome X	0.000149	0.000276	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—G6PD—metabolic syndrome X	0.000147	0.000274	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—FMO3—metabolic syndrome X	0.000147	0.000274	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—AGT—metabolic syndrome X	0.000147	0.000273	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—CD36—metabolic syndrome X	0.000145	0.00027	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—HDAC3—metabolic syndrome X	0.000144	0.000267	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—G6PD—metabolic syndrome X	0.000144	0.000267	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—APOE—metabolic syndrome X	0.000144	0.000267	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—APOA1—metabolic syndrome X	0.000142	0.000264	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—GCKR—metabolic syndrome X	0.000141	0.000261	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—LPA—metabolic syndrome X	0.000141	0.000261	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—HDAC3—metabolic syndrome X	0.00014	0.000261	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—TRIB3—metabolic syndrome X	0.00014	0.000261	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—metabolic syndrome X	0.000139	0.000258	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—GCKR—metabolic syndrome X	0.000137	0.000255	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—LPA—metabolic syndrome X	0.000137	0.000255	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—PLA2G6—metabolic syndrome X	0.000136	0.000253	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—G6PD—metabolic syndrome X	0.000136	0.000252	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—metabolic syndrome X	0.000135	0.000251	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—APOA5—metabolic syndrome X	0.000135	0.000251	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—PLA2G6—metabolic syndrome X	0.000133	0.000247	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—HDAC3—metabolic syndrome X	0.000132	0.000246	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—APOA5—metabolic syndrome X	0.000132	0.000245	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—EPHX2—metabolic syndrome X	0.000131	0.000244	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—MLXIPL—metabolic syndrome X	0.000131	0.000244	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—AGT—metabolic syndrome X	0.000131	0.000243	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—GCKR—metabolic syndrome X	0.000129	0.00024	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—LPA—metabolic syndrome X	0.000129	0.00024	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—APOE—metabolic syndrome X	0.000128	0.000238	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—metabolic syndrome X	0.000127	0.000236	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—NAMPT—metabolic syndrome X	0.000126	0.000234	CbGpPWpGaD
Levomilnacipran—ABCB1—Transmembrane transport of small molecules—PPARA—metabolic syndrome X	0.000125	0.000233	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—TRIB3—metabolic syndrome X	0.000125	0.000233	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—PLA2G6—metabolic syndrome X	0.000125	0.000233	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—metabolic syndrome X	0.000125	0.000233	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—LIPC—metabolic syndrome X	0.000125	0.000233	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—GCK—metabolic syndrome X	0.000125	0.000233	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—APOC3—metabolic syndrome X	0.000124	0.000231	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—APOA5—metabolic syndrome X	0.000124	0.00023	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—G6PC2—metabolic syndrome X	0.000123	0.000229	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—TRIB3—metabolic syndrome X	0.000122	0.000227	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—CETP—metabolic syndrome X	0.000121	0.000224	CbGpPWpGaD
Levomilnacipran—ABCB1—Transmembrane transport of small molecules—APOA1—metabolic syndrome X	0.000118	0.000219	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—SCARB1—metabolic syndrome X	0.000116	0.000215	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—TRIB3—metabolic syndrome X	0.000115	0.000214	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—ALB—metabolic syndrome X	0.000113	0.000209	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—NAMPT—metabolic syndrome X	0.000112	0.000209	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—SREBF1—metabolic syndrome X	0.000112	0.000209	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—metabolic syndrome X	0.000112	0.000208	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—GCK—metabolic syndrome X	0.000112	0.000208	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—LIPC—metabolic syndrome X	0.000112	0.000208	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—APOC3—metabolic syndrome X	0.000111	0.000206	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—NAMPT—metabolic syndrome X	0.00011	0.000204	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—HMGCR—metabolic syndrome X	0.000109	0.000203	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—GOT2—metabolic syndrome X	0.000109	0.000203	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—LIPC—metabolic syndrome X	0.000109	0.000203	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—GCK—metabolic syndrome X	0.000109	0.000203	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—APOC3—metabolic syndrome X	0.000108	0.000201	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—CETP—metabolic syndrome X	0.000108	0.0002	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—CETP—metabolic syndrome X	0.000105	0.000196	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—FABP4—metabolic syndrome X	0.000105	0.000195	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—NAMPT—metabolic syndrome X	0.000103	0.000192	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—metabolic syndrome X	0.000103	0.000192	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—SCARB1—metabolic syndrome X	0.000103	0.000192	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—LIPC—metabolic syndrome X	0.000103	0.000191	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—GCK—metabolic syndrome X	0.000103	0.000191	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—APOC3—metabolic syndrome X	0.000102	0.00019	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—SCARB1—metabolic syndrome X	0.000101	0.000187	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—ALB—metabolic syndrome X	0.0001	0.000187	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—SREBF1—metabolic syndrome X	0.0001	0.000186	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—HSD11B1—metabolic syndrome X	9.94e-05	0.000185	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—CETP—metabolic syndrome X	9.91e-05	0.000184	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	9.85e-05	0.000183	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—SREBF1—metabolic syndrome X	9.78e-05	0.000182	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—GOT2—metabolic syndrome X	9.74e-05	0.000181	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—HMGCR—metabolic syndrome X	9.74e-05	0.000181	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—ABCA1—metabolic syndrome X	9.73e-05	0.000181	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—SLC2A4—metabolic syndrome X	9.73e-05	0.000181	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—HMGCR—metabolic syndrome X	9.51e-05	0.000177	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—GOT2—metabolic syndrome X	9.51e-05	0.000177	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—SCARB1—metabolic syndrome X	9.49e-05	0.000176	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—GOT1—metabolic syndrome X	9.42e-05	0.000175	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—GGT1—metabolic syndrome X	9.42e-05	0.000175	CbGpPWpGaD
Levomilnacipran—ABCB1—Transmembrane transport of small molecules—ALB—metabolic syndrome X	9.32e-05	0.000173	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—SREBF1—metabolic syndrome X	9.21e-05	0.000171	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—HMGCR—metabolic syndrome X	8.96e-05	0.000167	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—GOT2—metabolic syndrome X	8.96e-05	0.000167	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—G6PD—metabolic syndrome X	8.86e-05	0.000165	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—AKT1—metabolic syndrome X	8.83e-05	0.000164	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	8.79e-05	0.000163	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—ABCA1—metabolic syndrome X	8.68e-05	0.000161	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—SLC2A4—metabolic syndrome X	8.68e-05	0.000161	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—HDAC3—metabolic syndrome X	8.65e-05	0.000161	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—ABCA1—metabolic syndrome X	8.48e-05	0.000158	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—SLC2A4—metabolic syndrome X	8.48e-05	0.000158	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—GCKR—metabolic syndrome X	8.45e-05	0.000157	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—LPA—metabolic syndrome X	8.45e-05	0.000157	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—GOT1—metabolic syndrome X	8.41e-05	0.000156	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—GGT1—metabolic syndrome X	8.41e-05	0.000156	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—GGT1—metabolic syndrome X	8.21e-05	0.000153	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—GOT1—metabolic syndrome X	8.21e-05	0.000153	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—PLA2G6—metabolic syndrome X	8.19e-05	0.000152	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—APOA5—metabolic syndrome X	8.1e-05	0.000151	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—APOB—metabolic syndrome X	7.99e-05	0.000149	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—ABCA1—metabolic syndrome X	7.99e-05	0.000149	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—SLC2A4—metabolic syndrome X	7.99e-05	0.000149	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—PLA2G4A—metabolic syndrome X	7.78e-05	0.000145	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—GGT1—metabolic syndrome X	7.74e-05	0.000144	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—GOT1—metabolic syndrome X	7.74e-05	0.000144	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—LPL—metabolic syndrome X	7.63e-05	0.000142	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—TRIB3—metabolic syndrome X	7.53e-05	0.00014	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—CD36—metabolic syndrome X	7.25e-05	0.000135	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—APOB—metabolic syndrome X	7.14e-05	0.000133	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—APOB—metabolic syndrome X	6.97e-05	0.00013	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—PLA2G4A—metabolic syndrome X	6.94e-05	0.000129	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—LPL—metabolic syndrome X	6.81e-05	0.000127	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—PLA2G4A—metabolic syndrome X	6.78e-05	0.000126	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—NAMPT—metabolic syndrome X	6.76e-05	0.000126	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—PPARA—metabolic syndrome X	6.74e-05	0.000125	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—LIPC—metabolic syndrome X	6.71e-05	0.000125	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—GCK—metabolic syndrome X	6.71e-05	0.000125	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—APOC3—metabolic syndrome X	6.67e-05	0.000124	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—LPL—metabolic syndrome X	6.65e-05	0.000124	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—APOB—metabolic syndrome X	6.56e-05	0.000122	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—AGT—metabolic syndrome X	6.53e-05	0.000121	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—CETP—metabolic syndrome X	6.48e-05	0.00012	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—CD36—metabolic syndrome X	6.47e-05	0.00012	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—APOE—metabolic syndrome X	6.4e-05	0.000119	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—PLA2G4A—metabolic syndrome X	6.38e-05	0.000119	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—APOA1—metabolic syndrome X	6.33e-05	0.000118	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—CD36—metabolic syndrome X	6.32e-05	0.000118	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—LPL—metabolic syndrome X	6.27e-05	0.000117	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—SCARB1—metabolic syndrome X	6.2e-05	0.000115	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—SREBF1—metabolic syndrome X	6.02e-05	0.000112	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—PPARA—metabolic syndrome X	6.02e-05	0.000112	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—CD36—metabolic syndrome X	5.95e-05	0.000111	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—PPARA—metabolic syndrome X	5.87e-05	0.000109	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—HMGCR—metabolic syndrome X	5.86e-05	0.000109	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—GOT2—metabolic syndrome X	5.86e-05	0.000109	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—AGT—metabolic syndrome X	5.83e-05	0.000108	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—APOE—metabolic syndrome X	5.71e-05	0.000106	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—AGT—metabolic syndrome X	5.69e-05	0.000106	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—APOA1—metabolic syndrome X	5.65e-05	0.000105	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—APOE—metabolic syndrome X	5.57e-05	0.000104	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—PPARG—metabolic syndrome X	5.57e-05	0.000104	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—PPARA—metabolic syndrome X	5.54e-05	0.000103	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—APOA1—metabolic syndrome X	5.51e-05	0.000102	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—INS—metabolic syndrome X	5.47e-05	0.000102	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—AGT—metabolic syndrome X	5.36e-05	9.97e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—APOE—metabolic syndrome X	5.25e-05	9.77e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—ABCA1—metabolic syndrome X	5.22e-05	9.71e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—SLC2A4—metabolic syndrome X	5.22e-05	9.71e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—APOA1—metabolic syndrome X	5.19e-05	9.66e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—GGT1—metabolic syndrome X	5.06e-05	9.4e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—GOT1—metabolic syndrome X	5.06e-05	9.4e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—ALB—metabolic syndrome X	5.01e-05	9.32e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—PPARG—metabolic syndrome X	4.97e-05	9.25e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—INS—metabolic syndrome X	4.88e-05	9.07e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—PPARG—metabolic syndrome X	4.86e-05	9.03e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—NOS3—metabolic syndrome X	4.79e-05	8.91e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—INS—metabolic syndrome X	4.76e-05	8.86e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—PPARG—metabolic syndrome X	4.58e-05	8.51e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—INS—metabolic syndrome X	4.49e-05	8.35e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—ALB—metabolic syndrome X	4.47e-05	8.32e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—PTGS2—metabolic syndrome X	4.38e-05	8.15e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—ALB—metabolic syndrome X	4.37e-05	8.12e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—APOB—metabolic syndrome X	4.29e-05	7.98e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—NOS3—metabolic syndrome X	4.28e-05	7.96e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—NOS3—metabolic syndrome X	4.18e-05	7.77e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—PLA2G4A—metabolic syndrome X	4.17e-05	7.76e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—ALB—metabolic syndrome X	4.11e-05	7.65e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—LPL—metabolic syndrome X	4.1e-05	7.62e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—NOS3—metabolic syndrome X	3.94e-05	7.32e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—PTGS2—metabolic syndrome X	3.91e-05	7.28e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—CD36—metabolic syndrome X	3.89e-05	7.24e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—PTGS2—metabolic syndrome X	3.82e-05	7.1e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—PPARA—metabolic syndrome X	3.62e-05	6.73e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—PTGS2—metabolic syndrome X	3.6e-05	6.69e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—AGT—metabolic syndrome X	3.51e-05	6.52e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—APOE—metabolic syndrome X	3.43e-05	6.39e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—APOA1—metabolic syndrome X	3.4e-05	6.31e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—PPARG—metabolic syndrome X	2.99e-05	5.56e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—INS—metabolic syndrome X	2.93e-05	5.46e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—ALB—metabolic syndrome X	2.69e-05	5e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—NOS3—metabolic syndrome X	2.57e-05	4.78e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—PTGS2—metabolic syndrome X	2.35e-05	4.38e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—AKT1—metabolic syndrome X	2.2e-05	4.1e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—AKT1—metabolic syndrome X	1.97e-05	3.66e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—AKT1—metabolic syndrome X	1.92e-05	3.57e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—AKT1—metabolic syndrome X	1.81e-05	3.36e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—AKT1—metabolic syndrome X	1.18e-05	2.2e-05	CbGpPWpGaD
